The lower levels of prostate-specific antigen in men with diabetes may reduce the likelihood of referral for further investigation, leading to lower detection rates of less aggressive prostate cancer44-46 but not necessarily lower mortality. The gene discussed is KLK3; the disease is diabetes mellitus.